To evaluate the impact of antiplatelet therapy (APT)on the incidence of hepatocellular carcinoma (HCC) and mortality following its treatment.
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma
Giannini, Edoardo G
2022-01-01
Abstract
To evaluate the impact of antiplatelet therapy (APT)on the incidence of hepatocellular carcinoma (HCC) and mortality following its treatment.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Eur J Clin Invest platelets.pdf
accesso aperto
Tipologia:
Documento in versione editoriale
Dimensione
3.92 MB
Formato
Adobe PDF
|
3.92 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
